Membership Update – July 2011

BioNJ welcomes our new Diamond Members for 2011:

Campbell Alliance
Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm’s clients include most of the world’s top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Pricing and Market Access, Medical Affairs, and Sales. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and Zug, Switzerland, the firm serves clients throughout North America, Europe, and Japan. For more information, please visit Campbell Alliance.

Citigroup’s Global Investment Banking unit provides comprehensive financial advisory and capital-raising services to top corporations, financial institutions, and governments worldwide. Clients receive tailored financial solutions and strategic advisory services on a wide range of M&A transactions and capital-raising activities including mergers, acquisitions, divestitures, financial restructurings, underwriting and distributing equity, debt, and derivative securities.

Citi is the preeminent global investment banking firm as well as the foremost global underwriter in combined equity and debt issuance. Citi has cutting-edge capabilities in every part of the globe for virtually every financial services product that our clients need. The bankers are organized into industry, product, and regional groups and work closely with our partners in capital markets, sales and trading, research, and global relationship banking to offer customized financing strategies for our clients.

This combined expertise allows us to offer the most innovative and comprehensive ideas and solutions in all market conditions by bankers who have in-depth industry knowledge, local market acumen, product creativity, and execution expertise.

BioNJ welcomes our new Platinum Member for 2011:

Fragomen, Del Rey, Bernsen & Loewy, LLP
Fragomen is recognized as the world’s leading immigration law firm. Immigration is not just a practice area within our firm – it is our only practice. We provide comprehensive immigration services for short- and long-term international assignments, permanent transfers, and the local hire of foreign workers. Our knowledge of international legal, regulatory, and policy issues allows us to provide our clients with strategic advice and effective and efficient immigration solutions to assist them in achieving and maintaining a competitive edge in the global marketplace.

BioNJ thanks our Platinum Members that have renewed their membership for 2011:

KPMG LLP, the audit, tax, and advisory firm, is the U.S. member firm of KPMG International. KPMG delivers a globally consistent set of multidisciplinary services based on deep industry knowledge. Our industry focus helps KPMG professionals develop a rich understanding of clients’ businesses and the insight, skills, and resources required to address industry-specific issues and opportunities.

LifeCell Corporation
LifeCell develops and markets innovative biologically based products in the emerging field of regenerative medicine for use in reconstructive, orthopedic, and urogynecologic surgical procedures.

BioNJ welcomes our new Core Members for 2011:

Cancer Genetics, Inc.
Cancer Genetics, Inc. (CGI) is an emerging leader in the field of personalized medicine, offering products and services that enable cancer diagnostics as well as treatments that are tailored to the specific genetic profile of the individual. Products and services being developed at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs.

CGI’s cutting-edge proprietary tests and state-of-the-art reference laboratory provide critical genomic information where patients and their physicians need it most – to diagnose, monitor, and inform cancer treatment.

CGI is committed to maintaining the standard of clinical excellence through its investment in outstanding facilities and equipment. Our reference laboratory is both CLIA certified and CAP accredited. In addition, we have approvals and accreditations from the states of Florida, Maryland, New York, and New Jersey.

Founded in 1999 by world-renowned cytogeneticist Dr. R.S.K. Chaganti, CGI’s scientific advisory board includes leading specialists in clinical cytogenetics, as well as significant thought leaders capable of driving adoption in the tri-state area. The company has been built on a foundation of world-class scientific knowledge and IP in solid and bloodborne cancers, as well as strong academic relationships with major cancer centers, such as Memorial Sloan-Kettering and the National Cancer Institute.

CGI is focused on delivering products and services that drive the highest levels of patient value. To achieve this, we have developed a corporate culture that inspires innovation, respects knowledge and fosters leadership. CGI’s dedicated staff takes pride in our specialized laboratory services, superior turnaround time (TAT), enhanced reporting, EMR integration, and ongoing research and development for new tests.

CGI’s full-service cancer genetic practice and path to innovation with research makes for optimal patient care management.

In the world of biologics, MedImmune has established itself as a true visionary, with one of the most robust pipelines in the biopharmaceutical industry. From groundbreaking research and development, to state-of-the-art manufacturing, to product commercialization, every day we’re touching people’s lives.

Since its founding in 1988 in Gaithersburg, MD, MedImmune has distinguished itself as an innovator in developing and commercializing vaccines as well as biologics – agents synthesized from living organisms or their products and used medically as a preventive or therapeutic agent. The company developed and commercialized the first monoclonal antibody for an infectious disease to be approved for use in the United States, representing the first breakthrough in influenza technology in more than 60 years.

MedImmune is home to a talented team of motivated professionals who are inspired by the possibility of helping people live longer, healthier, and more satisfying lives. From the scientist in the lab, to the medical affairs directors, to the manufacturing experts, to those in departments such as finance or legal, people work at MedImmune to make a difference. With integrity, accountability, commitment, and teamwork, the company thrives in a unique culture that inspires us, often challenges us, and always drives us to succeed in the constantly evolving landscape of our industry. For more information please visit MedImmune.

BioNJ welcomes our new Associate Members for 2011:

Cambridge BioMedical, Inc.
Cambridge Biomedical is a contract laboratory service organization that works with biotechnology, pharmaceutical, and reference laboratories. We specialize in custom assay development, qualification, and validation. Assays are performed in our CLIA/CAP-accredited laboratory. Testing capabilities include clinical trial, diagnostic, and biosafety testing. Cambridge Biomedical offers a wide variety of analytic technologies in microbiology, immunology, molecular biology, and clinical chemistry, including HPLC, ELISA, and RIA, Cell-Based Assays, Cell Culture, RT PCR, Colorimetric Assays, and Spectroscopy. We are experts at solving assay development problems. Let our Science and Service® commitment work for you.

Cambridge Biomedical’s laboratories specialize in custom solutions for your testing needs in support of Pre-clinical and Phase I-IV clinical trials. We can perform testing under Good Laboratory Practices Guidelines (21 CFR, Part 58). Our clinical laboratory is CLIA certified, CAP accredited, and registered with the FDA. Additional permits allow us to perform clinical diagnostic tests from specimens from all 50 U.S. states. Our Quality Assurance Unit oversees the regulatory compliance of all GLP testing and timelines of the auditing and reporting processes.

We are experts at satisfying our clients’ needs. We take great pride in the fact that we are staffed and equipped to deal with unusual challenges to integrate our Science and Service® commitment. Our highly knowledgeable and skilled staff has many years of laboratory and industry experience. Our method of partnering with our clients is to work together closely to develop customized protocols that meet their organization’s needs and maximize their project’s success. Cambridge Biomedical’s unique capabilities include extensive scientific experience, a broad range of technologies, and solid quality systems. We are experts at providing Custom Solutions for Life Sciences Companies™. These key attributes provide a solid understanding of our clients’ needs that enables us to effectively support the requirements of life sciences companies.

DRS Corp.
Data Reduction Systems Corporation (DRS) leverages 25+ years of document management and software development for the life science industry, to provide best-in-class essential study document services and technology.

DRS’s ClinDoc service assists our clients in collecting and processing of all essential study documents. Document collection is carried out electronically through a secure web portal, in paper, or using a hybrid model. DRS also offers subject case book preparation for FDA submission, including templates, hyperlinking and bookmarking, and redaction to complete its end-to-end full-service offering.

DRS is a customer-driven service organization utilizing technology to provide comprehensive and cost-effective flexible service solutions.

Scientific Search
Scientific Search has been placing MDs, PhDs, Regulatory Affairs, Quality Assurance, Pre-Clinical, and Clinical Development and Management, Pharmacovigilance, Toxicology, Engineering, Market Research, R&D, Information Technology, and related professionals at the technical, management, and executive levels since 1983. This includes significant work throughout the mid-Atlantic region of the United States. Our firm has very extensive resources in terms of recruiters and – most important – biotechnology industry contacts, which enable us to find the right people quickly. We fill full-time direct, as well as temporary, and temp-to-direct positions. Additional information is available at

Triana Life Sciences
The Triana Group enables companies to grow and compete in the global marketplace by accessing new markets and next-generation products internationally. With a business model ranging from fee-for-service to venturing, and various agreements in between, it specializes in technologies that bring new value to key industries: medical, healthcare, and life sciences; industrial sectors; services, including finance, and the digital marketing chain; and increasingly, other fields.

Triana enables its clients, partner companies, and investors to meet their international business needs – from planning to assembling the talent, capital, and intangible resources necessary to execute their market expansion strategies. Its teams and investors are experienced in business development, mergers, acquisitions, and joint ventures, in selected countries. Its offices are in Paris, New York, Philadelphia, and San Jose, and it has partners and joint ventures in Germany and the Gulf Countries.

BioNJ thanks We Work for Health for renewing its Institutional Membership for 2011:

We Work For Health
We Work for Health brings together leaders in research, medicine, public health, academia, education, labor, and business to raise awareness of the importance of preserving medical innovation. This unique network seeks to demonstrate to federal policymakers, key opinion leaders, and the media the need for strong public policy to promote innovation and, along with it, the health of Americans and the economy.